Veterinary Medicines

Alpha ERM Salar, injeksjonsvæske, suspensjon til atlantisk laks

Authorised
  • Yersinia ruckeri, serotype O1b, strain AL 3253, Inactivated
Download as PDF

Product identification

Medicine name:
Alpha ERM Salar, injeksjonsvæske, suspensjon til atlantisk laks
Active substance:
  • Yersinia ruckeri, serotype O1b, strain AL 3253, Inactivated
Target species:
  • Atlantic salmon
Route of administration:
  • Intraperitoneal use

Product details

Active substance and strength:
  • Yersinia ruckeri, serotype O1b, strain AL 3253, Inactivated
    70.00
    Relative Percentage Survival
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Atlantic salmon
      • All relevant tissues
        0
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq AS
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 19-12915
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 18/02/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 18/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."